FDA approves Cepheid's Xpert HCV test and GeneXpert Xpress System [Yahoo! Finance]
Danaher Corporation (DHR)
Last danaher corporation earnings: 1/30 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.danaher.com
Company Research
Source: Yahoo! Finance
This marks the first point-of-care hepatitis C RNA test that can be used in various healthcare settings, including substance use disorder treatment facilities, correctional facilities, and emergency departments. The test delivers results in about one hour using a fingertip blood sample. It can now be used in settings with a Clinical Laboratory Improvement Amendments (CLIA) Certificate of Waiver. This development allows for a test-and-treat approach, potentially offering treatment during the same healthcare visit for those who test positive for hepatitis C RNA. Previously, hepatitis C testing required sending samples to a central lab, often causing delays in diagnosis and treatment. The new test aims to streamline the process and improve patient outcomes by reducing the need for follow-up appointments. The test's validation data was gathered through the Independent Test Assessment Program (ITAP), part of the National Institutes of Health's Rapid Acceleration of Diagnostics T
Show less
Read more
Impact Snapshot
Event Time:
DHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DHR alerts
High impacting Danaher Corporation news events
Weekly update
A roundup of the hottest topics
DHR
News
- The best TVs under $500 in 2024 [Business Insider]Business Insider
- Cepheid Receives FDA Authorization with CLIA Waiver for Xpert® HCV [Yahoo! Finance]Yahoo! Finance
- Cepheid Receives FDA Authorization with CLIA Waiver for Xpert® HCVPR Newswire
- X-Rite Autura Ink Wins PRINTING United Alliance 2024 Pinnacle Product Award [Yahoo! Finance]Yahoo! Finance
- Danaher Co. (NYSE: DHR) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
DHR
Earnings
- 4/23/24 - Beat
DHR
Sec Filings
- 6/20/24 - Form 8-K
- 6/7/24 - Form 11-K
- 5/17/24 - Form 4
- DHR's page on the SEC website